ALLOMAP

Serial Number 78353208
Registration 3442169
800

Registration Progress

Application Filed
Jan 16, 2004
Under Examination
Approved for Publication
Published for Opposition
Oct 19, 2004
Registered
Jun 3, 2008

Basic Information

Serial Number
78353208
Registration Number
3442169
Filing Date
January 16, 2004
Registration Date
June 3, 2008
Published for Opposition
October 19, 2004
Renewal Date
June 3, 2018
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 8, 2018
Registration
Registered
Classes
005

Rights Holder

CAREDX, INC.

03
Address
3260 BAYSHORE BOULEVARD
BRISBANE, CA 94005

Ownership History

Expression Diagnostics, Inc.

Original Applicant
03
South San Francisco, CA

Expression Diagnostics, Inc.

Owner at Publication
03
Brisbane, CA

XDX, INC.

New Owner After Publication #1
03
BRISBANE, CA

XDX, INC.

Original Registrant
03
BRISBANE, CA

CAREDX, INC.

New Owner After Registration #1
03
BRISBANE, CA

Legal Representation

Attorney
Theresa Conduah

USPTO Deadlines

Next Deadline
1061 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-06-03)
Due Date
June 03, 2028
Grace Period Ends
December 03, 2028

Application History

50 events
Date Code Type Description
Mar 27, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2018 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 8, 2018 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 8, 2018 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 8, 2018 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jun 8, 2018 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 30, 2018 E89R I TEAS SECTION 8 & 9 RECEIVED
Jun 3, 2017 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 17, 2014 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 17, 2014 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 17, 2014 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 11, 2014 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 3, 2014 E815 I TEAS SECTION 8 & 15 RECEIVED
Dec 23, 2013 CORV 4 REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Dec 13, 2013 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 3, 2008 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 30, 2008 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Apr 27, 2008 ALIE A ASSIGNED TO LIE
Apr 21, 2008 CNEA F EXAMINER'S AMENDMENT MAILED
Apr 21, 2008 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 21, 2008 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 20, 2008 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Apr 20, 2008 SNEA W SU-EXAMINER'S AMENDMENT WRITTEN
Apr 20, 2008 XAEC I EXAMINER'S AMENDMENT ENTERED
Apr 9, 2008 ALIE A ASSIGNED TO LIE
Mar 8, 2008 ALIE A ASSIGNED TO LIE
Feb 14, 2008 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Feb 11, 2008 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Jan 11, 2008 EISU I TEAS STATEMENT OF USE RECEIVED
Jan 11, 2008 IUAF S USE AMENDMENT FILED
Oct 10, 2007 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 18, 2007 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 18, 2007 EXT5 S SOU EXTENSION 5 FILED
Jun 18, 2007 EX5G S SOU EXTENSION 5 GRANTED
Mar 6, 2007 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 6, 2007 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 11, 2006 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 11, 2006 EXT4 S SOU EXTENSION 4 FILED
Dec 11, 2006 EX4G S SOU EXTENSION 4 GRANTED
May 24, 2006 EEXT I SOU TEAS EXTENSION RECEIVED
May 24, 2006 EXT3 S SOU EXTENSION 3 FILED
May 24, 2006 EX3G S SOU EXTENSION 3 GRANTED
Jan 13, 2006 EX2G S SOU EXTENSION 2 GRANTED
Dec 19, 2005 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 19, 2005 EXT2 S SOU EXTENSION 2 FILED
Jul 1, 2005 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2005 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 1, 2005 EXT1 S SOU EXTENSION 1 FILED

Detailed Classifications

Class 005
Biological chemical test kits for medical laboratory use in analysis of gene expression, inflammatory, cardiovascular, diseases, disorders
First Use Anywhere: 20060300
First Use in Commerce: 20060300

Additional Information

Pseudo Mark
ALLO MAP

Classification

International Classes
005